Zobrazeno 1 - 10 of 50 pro vyhledávání: '"Betty Y, Chang"'
2
Supplementary Figure 3 from Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Autor: Laurence Elias, Betty Y. Chang, Juthamas Sukbuntherng, Taisei Kinoshita, Jun Chen
Supplementary Figure S3. Response of cell signaling pathways to treatment with ibrutinib in multiple cell lines. Cells were treated for 1 hour with ibrutinib. 50,000 cells were loaded in each lane.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a9ec84c461ecc62b2d44b50b3dac791
https://doi.org/10.1158/1535-7163.22508073.v1
Zobrazit plný text záznamu
3
Supplementary Figure 2 from Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Autor: Laurence Elias, Betty Y. Chang, Juthamas Sukbuntherng, Taisei Kinoshita, Jun Chen
Supplementary Figure S2. Response of BT-474 (A) and SK-BR-3 (B) cells to treatment with different ErbB kinase inhibitors. The cells were treated with inhibitors continuously for 72 hours, and alamarBlue® assay was used to quantify cell growth.
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::032b59d63d16ad874db1b4b2674bcdb0
https://doi.org/10.1158/1535-7163.22508076.v1
Zobrazit plný text záznamu
7
Supplementary Figure 5 from Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Autor: Laurence Elias, Betty Y. Chang, Juthamas Sukbuntherng, Taisei Kinoshita, Jun Chen
Supplementary Figure S5. Ibrutinib irreversibly inhibited SK-BR-3 cells, and bound covalently to EGFR and HER4 in rapid dilution assays. (A) SK-BR-3 cells were treated with ibrutinib at 0.1 and 0.5 µM for varied times before washing twice with fre
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb4ceab206717ec04678c4a164b75dd
https://doi.org/10.1158/1535-7163.22508067.v1
Zobrazit plný text záznamu
8
Supplementary Figure 4 from Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Autor: Laurence Elias, Betty Y. Chang, Juthamas Sukbuntherng, Taisei Kinoshita, Jun Chen
Supplementary Figure S4. Ibrutinib inhibited the growth of BT-474 xenograft tumors and related signaling pathways in the tumor samples. (A) Inhibition of BT-474 xenograft growth in NOD-SCID mice by ibrutinib administered at once -daily doses of 3 mg/
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b54e5ed297905f65db178c4c5e9f917
https://doi.org/10.1158/1535-7163.22508070.v1
Zobrazit plný text záznamu
10
Supplementary Figure 1 from Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth
Autor: Laurence Elias, Betty Y. Chang, Juthamas Sukbuntherng, Taisei Kinoshita, Jun Chen
Supplementary Figure S1. Response of MDA-MB-361 cells to multiple inhibitors. MD-MB-361 cells were plated in 96-well plates overnight before treatment with inhibitors for 72 hours. CellTiter-Glo® was used for quantifying cell growth. The assay was
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5076069814bfcbd7bf81bc5d9e53c85d
https://doi.org/10.1158/1535-7163.22508079
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje